≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_NASOPHARYNX_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C11
  • Hospital discharge: ICD-9 — 147
  • Hospital discharge: ICD-8 — 147
  • Cause of death: ICD-10 — C11
  • Cause of death: ICD-9 — 147
  • Cause of death: ICD-8 — 147
  • Cancer registry: Topography ICD-O-3 — C11
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

164

4. Check minimum number of events

None

164

5. Include endpoints

None

164

6. Filter based on genotype QC (FinnGen only)

164

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 164 61 103
Unadjusted period prevalence (%) 0.04 0.02 0.05
Median age at first event (years) 61.38 58.39 63.16

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
96
Matched controls
960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
63.8
54
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
+∞
48.0
42
*
A03FA01
ATC
metoclopramide; systemic, rectal
30.8
42.1
61
51
JDB10
NOMESCO Finland
Percutaneous gastrostomy
322.6
41.4
39
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
40.4
40.6
52
27
WF002
NOMESCO Finland
Radical radiotherapy
521.2
36.6
34
*
8070/3-C11.9
ICD-O-3
Squamous cell carcinoma, NOS, of nasopharynx, NOS
+∞
35.7
32
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
32.1
29
*
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
32.1
29
*
H02AB02
ATC
dexamethasone; systemic
214.9
30.6
30
*
N02AA05
ATC
oxycodone; systemic
18.1
26.0
43
41
A04AA02
ATC
granisetron; systemic, transdermal
+∞
25.1
23
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
10.8
24.8
63
144
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
+∞
23.9
22
*
C11.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of nasopharynx
+∞
22.8
21
*
A04AA01
ATC
ondansetron; systemic, rectal
55.4
21.7
25
6
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
249.3
20.4
20
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
249.3
20.4
20
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
19.4
18
*
XX3DW
NOMESCO Finland
Time consuming IT work
22.7
19.4
28
17
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
18.3
17
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
18.3
17.9
28
21
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
109.5
17.2
18
*
C11.1
ICD-10 Finland
Malignant neoplasm: Posterior wall of nasopharynx
+∞
17.2
16
*
C11.0
ICD-10 Finland
Malignant neoplasm: Superior wall of nasopharynx
+∞
17.2
16
*
C11.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of nasopharynx
+∞
17.2
16
*
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
+∞
17.2
16
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
+∞
16.1
15
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
15.0
14
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
15.0
14
*
H65.2
ICD-10 Finland
Chronic serous otitis media
63.2
14.3
16
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
15.5
14.0
23
19
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
13.9
13
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
13.9
13
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
27.2
13.5
18
8
EP1AE
NOMESCO Finland
Neck ultrasound examination
14.6
13.1
22
19
EBA10
NOMESCO Finland
Surgical removal of tooth
9.2
12.9
28
41
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
12.8
12
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
11.7
11
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
40.4
11.6
14
*
A07AA02
ATC
nystatin; oral
11.7
10.9
20
21
L03AA13
ATC
pegfilgrastim; parenteral
+∞
10.6
10
*
8010/3-C11.9
ICD-O-3
Carcinoma, NOS, of nasopharynx, NOS
+∞
10.6
10
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.6
10
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
10.6
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.6
10
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
10.6
10
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
45.1
10.2
12
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
45.1
10.2
12
*
JN4BD
NOMESCO Finland
Extensive body CT
13.5
10.0
17
15
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
7.0
9.8
25
46
DHA10
NOMESCO Finland
Biopsy of cavity of nose
110.5
9.6
10
*
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
110.5
9.6
10
*
A04AD12
ATC
aprepitant; systemic
+∞
9.5
9
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
9.5
9
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.5
9
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
9.5
9
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
9.5
9
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
5.1
9.2
32
86
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
12.5
9.2
16
15
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
22.5
8.7
12
6
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
98.3
8.6
9
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
8.4
8
*
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
8.4
8
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
R13
ICD-10 Finland
Dysphagia
8.6
8.4
18
25
WX408
NOMESCO Finland
General anesthesy, balanced
4.2
8.3
36
120
WX199
NOMESCO Finland
Other local analgesia
14.8
8.2
13
10
UDM02
NOMESCO Finland
Sinoscopy
15.0
7.6
12
9
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
8.5
7.6
16
22
K11.70
ICD-10 Finland
Hypoptyalism
86.5
7.5
8
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
86.5
7.5
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.4
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.4
7
*
8070/3-C11.2
ICD-O-3
Squamous cell carcinoma, NOS, of lateral wall of nasopharynx
+∞
7.4
7
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
+∞
7.4
7
*
J01CE02
ATC
phenoxymethylpenicillin; oral
3.7
7.1
77
500
Z51.5
ICD-10 Finland
Palliative care
15.3
7.1
11
8
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.2
6.9
52
258
H66.0
ICD-10 Finland
Acute suppurative otitis media
8.9
6.9
14
18
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
9.8
6.8
13
15
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.5
6.8
20
44
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
74.6
6.5
7
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
10.4
6.5
12
13
TDA90
NOMESCO Finland
Removal wax from ear
28.8
6.3
8
*
A01AB09
ATC
miconazole; local oral
5.6
6.3
18
38
8070/3-C11.1
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of nasopharynx
+∞
6.3
6
*
JN6AD
NOMESCO Finland
CT of torso and neck
+∞
6.3
6
*
8072/3-C11.9
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of nasopharynx, NOS
+∞
6.3
6
*
L03AA02
ATC
filgrastim; parenteral
+∞
6.3
6
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.6
6.3
14
21
WX110
NOMESCO Finland
Local anesthesy
3.2
6.3
71
452
JN4AD
NOMESCO Finland
Body CT examination
9.6
6.3
12
14
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
6.6
6.1
15
26
WZC30
NOMESCO Finland
Teaching
5.0
6.1
19
45
H66.9
ICD-10 Finland
Otitis media, unspecified
9.0
6.0
12
15
EMB10
NOMESCO Finland
Tonsillectomy
16.3
6.0
9
6

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
45
32
19.00
51.41
1.5
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
15
12.53
16.47
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
76
344
3.25
12.32
3.0
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
43
137
3.90
12.04
2.1
1.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
92
520
2.75
9.26
6.7
5.4
%
0.7
0.7
0.04
85
484
(3013650) Neutrophils [#/volume] in Blood by Automated count
107
662
2.77
8.87
15.2
6.2
e9/l
3.9
4.3
1.02
93
580
(3044640) Blood type and Crossmatch panel - Blood
66
322
2.76
8.77
2.3
1.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
93
542
2.65
8.61
6.8
5.3
%
2.9
3.1
0.21
85
501
(3019069) Monocytes/100 leukocytes in Blood
93
544
2.64
8.51
7.1
5.6
%
9.0
8.6
0.55
86
507
(3024561) Albumin [Mass/volume] in Serum or Plasma
87
500
2.58
8.16
5.7
3.2
g/l
34.2
35.4
1.00
80
469
(3002030) Lymphocytes/100 leukocytes in Blood
93
557
2.55
7.92
7.0
5.4
%
26.4
27.6
0.35
87
515
(42870588) Differential panel, method unspecified - Blood
70
373
2.53
7.57
6.6
5.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
32
113
3.28
7.46
5.0
2.5
u/l
221.8
243.7
0.65
32
106
(3042936) Bacteria identified in Isolate by Culture
43
182
2.85
7.33
1.7
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
91
554
2.44
7.29
6.7
5.2
%
58.7
57.1
0.52
85
518
(3001604) Monocytes [#/volume] in Blood
93
581
2.39
6.90
6.5
5.1
e9/l
0.6
0.6
0.07
78
502
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
83
494
2.38
6.88
4.0
3.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
93
583
2.37
6.82
6.7
5.1
e9/l
0.0
0.0
1.15
78
510
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
14
7.54
6.77
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
14
7.54
6.77
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
24
75
3.58
6.73
1.7
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
94
601
2.32
6.47
6.8
5.2
e9/l
0.2
0.2
1.28
79
530
(3023368) Bacteria identified in Blood by Culture
61
324
2.41
6.46
3.7
3.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
93
593
2.31
6.43
6.8
5.2
e9/l
1.6
1.8
2.11
82
522
(3015377) Calcium [Moles/volume] in Serum or Plasma
67
376
2.32
6.22
4.9
2.0
mmol/l
2.4
2.3
0.09
59
317
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
240
2.41
5.73
2.3
1.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
90
596
2.13
5.33
8.8
5.3
mmol/l
1.2
1.2
0.05
81
513
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
30
4.24
4.52
1.8
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
80
530
1.99
4.50
7.5
4.9
mmol/l
1.2
1.2
0.48
75
471
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
56
3.27
4.38
1.3
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
13
7.25
4.22
1.2
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
76
506
1.94
4.12
6.9
9.2
inr
1.3
1.3
0.18
12
139
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
96
2.62
3.94
1.2
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
104
2.53
3.81
1.4
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
25
112
2.45
3.71
2.2
1.6
nmol/l
396.3
365.5
0.36
25
98
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
17
5.53
3.56
2.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
29
144
2.23
3.42
1.8
1.5
—
—
—
0
0
(3019225) pH of Specimen
24
111
2.36
3.32
4.3
3.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
125
2.28
3.30
1.4
1.7
—
—
—
0
0
(44790047)
6
7
8.84
3.29
1.2
1.3
—
—
—
0
0
(44790048)
6
7
8.84
3.29
1.2
1.3
—
—
—
0
0
(44790049)
6
7
8.84
3.29
1.2
1.3
—
—
—
0
0
(44806118)
6
7
8.84
3.29
1.2
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
20
86
2.51
3.23
5.1
5.0
%
1.1
0.9
—
9
26
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
20
4.70
3.16
1.9
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
104
1239
0.56
3.02
6.2
6.5
mmol/mol
40.6
40.9
0.10
94
1163
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
182
2.02
2.98
2.1
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
115
1330
0.55
2.94
5.2
5.3
mmol/l
2.8
2.7
0.41
105
1227
(3035637) Corticotropin [Mass/volume] in Plasma
6
9
6.87
2.89
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
18
4.61
2.83
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
18
80
2.40
2.72
5.5
5.3
%
0.0
0.1
—
9
23
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
43
2.93
2.71
2.1
4.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
74
2.45
2.68
1.4
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
106
1243
0.58
2.63
4.3
4.3
mmol/l
1.3
1.3
0.04
97
1135
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
25
130
2.09
2.63
1.6
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
111
1286
0.58
2.62
4.9
4.7
mmol/l
1.4
1.4
0.73
103
1187
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
25
3.75
2.61
1.2
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
116
955
1.73
2.60
12.1
5.0
u/l
80.3
77.7
0.27
111
878
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
76
2.38
2.54
1.9
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
29
474
0.53
2.52
3.1
3.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
16
4.52
2.50
1.3
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
8
6.40
2.39
2.6
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
17
4.25
2.38
1.1
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
13
4.75
2.29
2.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
42
273
1.72
2.26
11.4
4.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
114
1297
0.60
2.20
4.7
4.8
mmol/l
4.6
4.5
0.22
106
1204
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.12
2.08
2.8
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
20
3.61
2.08
1.9
3.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
42
280
1.67
2.05
1.5
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
129
1.91
1.98
1.7
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
16
3.85
1.95
1.3
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
53
2.36
1.85
19.7
8.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
12
4.26
1.83
1.4
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
49
351
1.56
1.78
4.5
3.2
ph
7.4
7.4
—
7
56
(3045424) Erythrocytes [Presence] in Urine
5
13
3.93
1.73
3.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
13
3.93
1.73
1.4
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
42
2.47
1.71
2.9
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
115
1279
0.66
1.55
5.0
4.8
mmol/l
6.1
6.1
0.12
105
1160
(40768797) Stomach Pathology biopsy report
27
174
1.66
1.49
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
38
2.45
1.48
2.2
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
22
2.79
1.45
2.2
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
122
0.39
1.44
2.8
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
107
928
1.44
1.40
4.9
4.0
mm/h
15.1
12.1
1.09
100
847
(3025159) Blasts/100 leukocytes in Blood
14
75
1.95
1.39
6.4
5.3
%
0.0
0.0
—
7
19
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
23
2.67
1.38
1.5
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
30
203
1.58
1.37
2.7
2.9
e6/l
2.5
2.0
0.20
18
105
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
17
3.00
1.37
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
17
3.00
1.37
1.4
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
45
340
1.45
1.24
3.5
2.4
umol/l
347.8
11044.0
2.52
38
292
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
95
1.76
1.19
3.1
2.1
ml/min/173m2
91.8
57.8
—
5
34
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
20
2.55
1.16
1.0
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
21
2.42
1.10
4.2
2.2
%
204.0
190.7
—
5
21
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
5
21
2.42
1.10
2.0
1.2
u/ml
48.6
13.0
—
5
21
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
32
2.24
1.09
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
47
1.97
1.04
6.3
4.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
37
1.93
0.95
2.3
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
46
1.78
0.84
2.6
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
23
165
1.46
0.83
1.7
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
84
939
0.78
0.80
3.8
3.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
2.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
51
606
0.77
0.79
5.6
3.7
ug/l
2.5
1.9
0.73
45
543
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
160
1.43
0.75
5.1
4.7
%
32.5
30.5
0.35
14
107
(40760892) CBC W Ordered Manual Differential panel - Blood
32
249
1.35
0.75
5.4
4.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
295
1.33
0.74
4.6
3.9
ng/l
343.5
230.7
0.13
31
248
(3026008) Bacteria identified in Urine by Culture
43
351
1.31
0.73
3.4
3.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
28
214
1.37
0.73
2.5
2.6
e6/l
0.5
1.1
1.63
15
116
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
58
493
1.27
0.73
1.7
2.1
nmol/l
75.3
77.2
0.19
52
432
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
26
1.95
0.71
1.4
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
11
69
1.64
0.70
1.8
1.4
g/l
0.7
1.1
2.30
11
64
(40761536) Microorganisms panel - Urine sediment
5
91
0.54
0.69
3.0
2.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
5
27
1.88
0.69
1.8
1.4
—
0.1
—
0
7
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
27
1.88
0.69
1.6
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14
200
0.67
0.68
1.1
1.3
iu/ml
10.3
30.7
—
6
64
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
65
566
1.25
0.66
1.9
1.9
pmol/l
92.6
93.2
0.04
31
287
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
101
0.58
0.64
1.0
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
340
0.75
0.63
2.4
2.5
ug/l
0.6
0.7
0.64
18
217
(3041096) Erythrocytes [Presence] in Urine by Automated
27
340
0.75
0.63
4.0
3.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
18
239
0.72
0.59
1.2
1.2
u/ml
1.0
1.7
—
6
73
(3012516) Albumin [Mass/volume] in Urine
36
431
0.79
0.58
2.6
3.2
mg/l
1577.1
205.8
0.41
25
284
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
36
297
1.27
0.57
1.6
1.8
pmol/l
496.1
428.2
0.41
30
249
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
55
1.48
0.57
1.3
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
60
526
1.22
0.56
10.8
7.8
e9/l
0.0
0.0
0.00
42
429
(3003396) Base excess in Arterial blood by calculation
19
143
1.37
0.55
13.6
6.2
mmol/l
2.4
1.5
0.43
11
117
(3037467) Urinalysis macro (dipstick) panel - Urine
91
832
1.21
0.55
4.9
4.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
101
934
1.21
0.54
5.2
3.6
pmol/l
14.8
14.9
0.14
93
836
(3004789) Transferrin [Mass/volume] in Serum or Plasma
21
164
1.32
0.49
2.1
2.3
g/l
2.4
2.3
0.10
21
152
(3049717) Cytology report of Urine Cyto stain
7
46
1.54
0.49
4.4
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
48
1.48
0.47
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
38
323
1.23
0.47
1.7
1.5
nmol/l
21.7
20.1
0.23
33
277
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
41
473
0.82
0.46
4.6
3.5
%
22.6
25.3
0.54
20
205
(3022145) Colonoscopy Study observation
16
121
1.36
0.46
1.1
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
38
440
0.82
0.45
2.7
3.1
mmol/l
7.5
7.7
0.12
30
372
(3012544) pH of Venous blood
17
131
1.33
0.44
2.9
3.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
57
1.42
0.43
1.4
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
32
271
1.22
0.41
2.0
1.7
mg/l
0.9
1.2
0.67
25
220
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
16
0.00
0.41
0.0
4.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
5
35
1.44
0.39
1.8
1.2
mg/l
20.9
59.7
—
5
26
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
5
35
1.44
0.39
1.8
1.2
mg/l
16.9
39.6
—
5
26
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
12
89
1.38
0.39
5.2
2.7
mmol/l
1.2
1.2
0.04
12
76
(3022217) INR in Platelet poor plasma by Coagulation assay
25
208
1.24
0.38
21.0
23.8
inr
1.7
1.4
—
9
29
(3022621) pH of Urine by Test strip
12
90
1.36
0.37
1.8
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
123
0.72
0.36
5.2
2.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
42
1.44
0.36
2.0
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
33
285
1.20
0.36
3.0
3.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
82
1.37
0.35
1.7
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
131
1353
0.84
0.33
27.4
15.0
umol/l
78.4
83.1
1.38
131
1353
(3009542) Hematocrit [Volume Fraction] of Blood
108
1131
0.87
0.33
25.0
13.8
%
38.2
40.4
1.32
74
786
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
117
1218
0.86
0.33
21.8
11.5
ml/min/173m2
79.1
77.1
0.49
99
997
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
131
1264
1.18
0.33
23.8
12.6
mg/l
25.9
23.7
0.29
126
972
(4010399)
7
97
0.71
0.32
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
99
0.69
0.31
1.4
3.4
—
—
—
0
0
(3000492) Spirometry study
9
116
0.76
0.28
1.7
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
63
1.28
0.28
1.3
1.8
—
—
—
0
0
(3015736) pH of Urine
52
476
1.14
0.28
3.0
3.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
8
67
1.20
0.26
1.0
1.2
u/ml
242.3
219.9
—
8
62
(3002582) Erythrocytes [#/volume] in Urine
42
380
1.14
0.26
3.6
3.0
e6/l
23.6
238.9
0.66
34
286
(3013512) EKG study
44
400
1.14
0.26
6.3
4.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
38
1.33
0.23
1.4
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
15
125
1.22
0.23
2.6
3.7
kpa
5.7
5.9
0.31
15
120
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
101
0.78
0.22
2.0
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
310.7
—
0
12
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
13
0.00
0.21
0.0
1.3
—
90.0
—
0
13
(3014111) Lactate [Moles/volume] in Serum or Plasma
13
108
1.22
0.21
12.1
6.2
mmol/l
1.4
1.4
0.07
13
103
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
14
0.00
0.20
0.0
1.5
—
34.5
—
0
14
(3016750) Collection duration of Urine
0
14
0.00
0.20
0.0
2.0
—
469.2
—
0
9
(3000330) Specific gravity of Urine by Test strip
10
82
1.23
0.17
3.9
3.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
99
1023
0.92
0.17
27.8
15.2
%
13.9
13.6
1.28
94
996
(3022313) Gas panel - Capillary blood
8
68
1.19
0.17
3.0
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
43
460
0.91
0.16
3.8
4.0
mg/mmol
1.0
8.1
3.93
28
298
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
72
1.12
0.16
3.0
2.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
29
265
1.11
0.16
1.7
1.7
nmol/l
1089.2
1259.5
0.56
23
204
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
9
78
1.16
0.15
1.3
1.3
—
61.8
—
0
5
(3009261) Glucose [Presence] in Urine by Test strip
59
620
0.92
0.15
3.8
3.6
estimate
0.0
0.0
—
8
96
(40761511) CBC panel - Blood by Automated count
129
1315
0.91
0.14
19.8
12.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
108
0.82
0.13
1.6
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
45
475
0.93
0.13
3.8
3.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
59
613
0.94
0.10
5.3
4.7
estimate
0.0
0.0
—
8
100
(3018095) Leukocytes [#/volume] in Urine
46
439
1.07
0.10
5.0
3.5
e6/l
30.9
85.4
0.99
35
309
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
166
0.89
0.10
6.1
7.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
88
1.15
0.08
10.2
3.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
36
343
1.06
0.08
3.4
2.8
e6/l
0.3
0.5
0.63
26
250
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
74
1.09
0.07
2.0
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
53
548
0.95
0.07
3.8
3.8
ng/l
30.5
48.7
0.82
44
389
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
75
1.07
0.07
1.5
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
34
325
1.06
0.07
3.3
2.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
46
444
1.05
0.07
3.2
3.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
68
667
1.03
0.04
3.0
2.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
32
309
1.04
0.04
4.1
3.9
estimate
0.0
0.0
—
8
98
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
115
1156
0.98
0.00
6.1
4.4
mu/l
2.2
1.9
0.86
109
1042
(3022948) Iron [Moles/volume] in Serum or Plasma
19
186
1.02
0.00
2.4
2.3
umol/l
9.1
13.9
4.13
19
168
(3035350) Ketones [Presence] in Urine by Test strip
60
605
0.99
0.00
3.8
3.5
estimate
0.0
0.0
—
6
104
(3007164) IgA [Mass/volume] in Serum or Plasma
23
225
1.03
0.00
2.4
1.3
g/l
2.6
2.8
0.26
17
131
(3024354) Oxygen [Partial pressure] in Venous blood
10
102
0.98
0.00
2.8
2.8
kpa
5.7
4.2
—
10
96
(3000991) Gas panel - Venous blood
10
98
1.02
0.00
15.8
8.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
9
0.00
0.00
0.0
5.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
1.2
—
0
7
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
67
0.89
0.00
2.0
2.2
%
1.8
1.0
—
6
67
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
10.5
—
1518.6
—
0
8
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
9.1
—
996.0
—
0
8
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.3
—
8.5
—
0
8
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
5
55
0.91
0.00
4.0
1.6
ug/l
472.0
338.8
—
5
48
(40757494) Bilirubin.total [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
64
0.94
0.00
1.5
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
2830.0
—
0
5
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
284.7
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_NASOPHARYNX_EXALLC – Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).